224 related articles for article (PubMed ID: 31878928)
1. Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance.
Peskó G; Jenei Z; Varga G; Apor A; Vágó H; Czibor S; Prohászka Z; Masszi T; Pozsonyi Z
Cardiovasc Ultrasound; 2019 Dec; 17(1):32. PubMed ID: 31878928
[TBL] [Abstract][Full Text] [Related]
2. Cardiac amyloidosis mimicking severe aortic valve stenosis - a case report demonstrating diagnostic pitfalls and role of dobutamine stress echocardiography.
Salinger T; Hu K; Liu D; Herrmann S; Lorenz K; Ertl G; Nordbeck P
BMC Cardiovasc Disord; 2017 Mar; 17(1):86. PubMed ID: 28330445
[TBL] [Abstract][Full Text] [Related]
3. Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis.
Cavalcante JL; Rijal S; Abdelkarim I; Althouse AD; Sharbaugh MS; Fridman Y; Soman P; Forman DE; Schindler JT; Gleason TG; Lee JS; Schelbert EB
J Cardiovasc Magn Reson; 2017 Dec; 19(1):98. PubMed ID: 29212513
[TBL] [Abstract][Full Text] [Related]
4. Outcomes From Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis and Left Ventricular Ejection Fraction Less Than 30%: A Substudy From the TOPAS-TAVI Registry.
Maes F; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto W; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Salah-Annabi M; Pelletier-Beaumont E; Côté M; Puri R; Pibarot P; Rodés-Cabau J
JAMA Cardiol; 2019 Jan; 4(1):64-70. PubMed ID: 30566185
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications.
Balciunaite G; Rimkus A; Zurauskas E; Zaremba T; Palionis D; Valeviciene N; Aidietis A; Serpytis P; Rucinskas K; Sogaard P; Glaveckaite S; Zorinas A; Janusauskas V
Hellenic J Cardiol; 2020; 61(2):92-98. PubMed ID: 31740363
[TBL] [Abstract][Full Text] [Related]
6. Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week.
Ternacle J; Krapf L; Mohty D; Magne J; Nguyen A; Galat A; Gallet R; Teiger E; Côté N; Clavel MA; Tournoux F; Pibarot P; Damy T
J Am Coll Cardiol; 2019 Nov; 74(21):2638-2651. PubMed ID: 31753206
[TBL] [Abstract][Full Text] [Related]
7. Myocardial Fibrosis in Classical Low-Flow, Low-Gradient Aortic Stenosis.
Rosa VEE; Ribeiro HB; Sampaio RO; Morais TC; Rosa MEE; Pires LJT; Vieira MLC; Mathias W; Rochitte CE; de Santis ASAL; Fernandes JRC; Accorsi TAD; Pomerantzeff PMA; Rodés-Cabau J; Pibarot P; Tarasoutchi F
Circ Cardiovasc Imaging; 2019 May; 12(5):e008353. PubMed ID: 31088148
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of global left ventricular longitudinal strain for risk stratification in low ejection fraction, low-gradient aortic stenosis: results from the multicenter True or Pseudo-Severe Aortic Stenosis study.
Dahou A; Bartko PE; Capoulade R; Clavel MA; Mundigler G; Grondin SL; Bergler-Klein J; Burwash I; Dumesnil JG; Sénéchal M; O'Connor K; Baumgartner H; Pibarot P
Circ Cardiovasc Imaging; 2015 Mar; 8(3):e002117. PubMed ID: 25681417
[TBL] [Abstract][Full Text] [Related]
10. Validation of conventional and simplified methods to calculate projected valve area at normal flow rate in patients with low flow, low gradient aortic stenosis: the multicenter TOPAS (True or Pseudo Severe Aortic Stenosis) study.
Clavel MA; Burwash IG; Mundigler G; Dumesnil JG; Baumgartner H; Bergler-Klein J; Sénéchal M; Mathieu P; Couture C; Beanlands R; Pibarot P
J Am Soc Echocardiogr; 2010 Apr; 23(4):380-6. PubMed ID: 20362927
[TBL] [Abstract][Full Text] [Related]
11. Safety and utility of dobutamine and pressure wire use in the hemodynamic assessment of low-flow, low-gradient aortic stenosis with reduced left ventricular ejection fraction.
Fanari Z; Gunasekaran PC; Shaukat A; Hammami S; Dawn B; Wiley M; Tadros P
Cardiovasc Revasc Med; 2018 Jun; 19(4):438-443. PubMed ID: 29402710
[TBL] [Abstract][Full Text] [Related]
12. [Electrocardiographic and echocardiographic features of patients with primary cardiac amyloidosis].
Cheng ZW; Tian Z; Kang L; Chen TB; Fang LG; Cheng KA; Zeng Y; Fang Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jul; 38(7):606-9. PubMed ID: 21055282
[TBL] [Abstract][Full Text] [Related]
13. Cardiac amyloidosis: an unusual cause of low flow-low gradient aortic stenosis with preserved ejection fraction.
Haloui F; Salaun E; Maysou L; Dehaene A; Habib G
Eur Heart J Cardiovasc Imaging; 2016 Apr; 17(4):383. PubMed ID: 26825321
[No Abstract] [Full Text] [Related]
14. [Cardiac scintigraphy-centered diagnostic process in transthyretin cardiac amyloidosis].
Ak Sivrikoz I; Çavuşoğlu Y
Turk Kardiyol Dern Ars; 2020 Jul; 48(5):514-521. PubMed ID: 32633270
[TBL] [Abstract][Full Text] [Related]
15. [Cardiac amyloidosis and aortic valve stenosis].
Erbel-Khurtsidze S; Seibel R; Moka D; Brandt-Mainz KTJA; Erbel R; Lichtenberg A
Herz; 2021 Oct; 46(5):485-496. PubMed ID: 34487196
[TBL] [Abstract][Full Text] [Related]
16. A Novel Approach to Cardiac Magnetic Resonance Scar Characterization in Patients Affected by Cardiac Amyloidosis: A Pilot Study.
Alfieri M; Guerra F; Lofiego C; Fogante M; Ciliberti G; Vagnarelli F; Barbarossa A; Principi S; Stronati G; Volpato G; Compagnucci P; Valeri Y; Tofoni P; Brugiatelli L; Capodaglio I; Esposto Pirani P; Argalia G; Schicchi N; Messano L; Centanni M; Giovagnoni A; Perna GP; Dello Russo A; Casella M
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674259
[No Abstract] [Full Text] [Related]
17. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
[TBL] [Abstract][Full Text] [Related]
18. Value of low-dose dobutamine stress echocardiography on defining true severe low gradient aortic stenosis in patients with preserved left ventricular ejection fraction.
Liu D; Hu K; Liebner E; Weidemann F; Herrmann S; Ertl G; Frantz S; Nordbeck P
Int J Cardiovasc Imaging; 2018 Dec; 34(12):1877-1887. PubMed ID: 30039338
[TBL] [Abstract][Full Text] [Related]
19. Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome.
Nitsche C; Aschauer S; Kammerlander AA; Schneider M; Poschner T; Duca F; Binder C; Koschutnik M; Stiftinger J; Goliasch G; Siller-Matula J; Winter MP; Anvari-Pirsch A; Andreas M; Geppert A; Beitzke D; Loewe C; Hacker M; Agis H; Kain R; Lang I; Bonderman D; Hengstenberg C; Mascherbauer J
Eur J Heart Fail; 2020 Oct; 22(10):1852-1862. PubMed ID: 32078212
[TBL] [Abstract][Full Text] [Related]
20. Comparison of magnetic resonance imaging versus Doppler echocardiography for the evaluation of left ventricular diastolic function in patients with cardiac amyloidosis.
Rubinshtein R; Glockner JF; Feng D; Araoz PA; Kirsch J; Syed IS; Oh JK
Am J Cardiol; 2009 Mar; 103(5):718-23. PubMed ID: 19231340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
